Stockscreener 앱 받기
100.53
1.30%
1.29
시간 외 거래:
100.97
0.44
+0.44%
전일 마감가:
$99.24
열려 있는:
$99.7
하루 거래량:
9.27M
Relative Volume:
1.12
시가총액:
$148.96B
수익:
$18.49B
순이익/손실:
$2.50B
주가수익비율:
59.84
EPS:
1.6801
순현금흐름:
$3.49B
1주 성능:
+5.88%
1개월 성능:
+2.76%
6개월 성능:
+5.69%
1년 성능:
+14.15%
1일 변동 폭
$99.59
$101.02
1주일 범위
$94.53
$101.02
52주 변동 폭
$80.64
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
100.53 | 147.05B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
ABT
Abbott Laboratories
|
129.51 | 223.72B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
SYK
Stryker Corp
|
381.22 | 143.14B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.92 | 122.86B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.29 | 43.82B | 5.69B | 1.41B | 577.90M | 6.9828 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Risk vs reward if holding onto Boston Scientific CorporationM&A Rumor & Low Risk Entry Point Tips - newser.com
What market sentiment indicators show for Boston Scientific Corporation stockWeekly Profit Report & Fast Moving Stock Watchlists - newser.com
Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Boston Scientific continues acquisition spree with $533M deal - The Business Journals
Boston Scientific Corp (BSX)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus
What Fibonacci levels say about Boston Scientific Corporation rebound2025 Volatility Report & Weekly Top Gainers Trade List - newser.com
Boston Scientific To Acquire Privately-Held Pain Solutions Developer Nalu Medical For About $533M - Stocktwits
Boston Scientific Corp (BSX.HM) latest press releases and corporate news - Yahoo
Published on: 2025-10-18 08:40:56 - nchmf.gov.vn
Boston Scientific (BSX): Assessing Valuation as Shares Post Steady Gains - Yahoo
Weekly Trades: Why Boston Scientific Corporation stock remains undervaluedEarnings Growth Report & Daily Price Action Insights - nchmf.gov.vn
Boston Scientific expands chronic pain portfolio, buys Nalu for $533M - BioWorld MedTech
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Buying Rest Of Pain Therapy Biz For $533M - Law360
Boston Scientific to acquire Nalu Medical for $533M - MassDevice
Boston Scientific Dives Into Chronic Pain Through New Acquisition - Medical Device and Diagnostic industry
Boston Scientific acquires Nalu Medical for $533m - Yahoo Finance
Boston Scientific to purchase California medtech for $533M - Worcester Business Journal
Boston Scientific To Acquire Nalu Medical In $600 Million Pain Relief Deal - Sahm
Boston Scientific To Acquire Nalu Medical In $600 Million Pain Relief Deal - Benzinga
Needham Reiterates Buy Rating for Boston Scientific (BSX) at $12 - GuruFocus
Boston Scientific boosts chronic pain therapy portfolio with Nalu deal - Reuters
Unlocking Q3 Potential of Boston Scientific (BSX): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Boston Scientific to acquire Nalu Medical for $533 million - Investing.com
Boston Scientific (BSX) to Acquire Nalu Medical in Strategic Mov - GuruFocus
Boston Scientific boosts chronic pain therapy portfolio with Nalu deal By Reuters - Investing.com
Boston Scientific to buy Nalu Medical for $533M - Yahoo Finance
$533M deal: Boston Scientific to acquire Nalu Medical, adding PNS tech; Nalu >$60M sales in 2025 - Stock Titan
Comparing Boston Scientific Corporation in custom built stock radarsJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Boston Scientific Corp (BSX.HM) latest stock news and headlines - Yahoo
Boston Scientific Corp (BSX.HM) Latest Press Releases & Corporate News - Yahoo
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Boston Scientific Corp (BSX.HM) Stock Price, News, Quote & History - Yahoo
Why Boston Scientific Corporation stock remains on watchlistsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com
Boston Scientific Corp (BSX.HM) interactive stock chart - Yahoo
Boston Scientific Corp (BSX.HM) stock major holders - Yahoo
Boston Scientific Corp (BSX.HM) analyst ratings, estimates and forecasts - Yahoo
Boston Scientific Corp (BSX.HM) Company Profile & Facts - Yahoo
What Makes Boston Scientific Corporation (BSX) an Investment Choice? - Yahoo Finance
Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025? - Yahoo Finance
Boston Scientific Corp (BSX.HM) Analyst Ratings, Estimates & Forecasts - Yahoo
Boston Scientific Corp (BSX.HM) company profile and facts - Yahoo
Boston Scientific Corp (BSX.HM) Income Statement - Yahoo
Boston Scientific Corp (BSX.HM) stock historical prices and data - Yahoo
Boston Scientific Corp (BSX.HM) insider ownership and holdings - Yahoo
OFI Invest Asset Management Has $1.38 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
What You Need To Know Ahead of Boston Scientific's Earnings Release - MSN
Aberdeen Group plc Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):